FK 749 is a distinctive new parenteral cephalosporin antibiotic with a broad antibacterial spectrum which is more potently active against a wide variety of Gram-negative bacilli, including the opportunistic pathogens such as Citrobacter and Enterobacter species and Serratia nrarcescens, than SCE 963, T 1551 and cefmetazole. The activity of FK 749 against Escherichia coli, Klebsiella pneumoniae, indole-positive and -negative Proteus species, Haemophilus influen_ae and Streptococcus pyogenes was by far superior to that of the three other antibiotics. These test organisms were not resistant to FK 749. The antibacterial activity of FK 749 against Pseudarnonas aeruginosa was almost the same as that of ticarcillin but was inferior to that of gentamicin and T 1551. The bactericidal activity of FK 749 against E. coli, K. pneumoniae and Proteus mirabilis was more potent than that of the three other antibiotics. FK 749, like cefmetazole, was extremely stable to /3-lactaniases. In studies in mice, the therapeutic effect of subcutaneous injection of FK 749 against various infections due to Gram-negative bacilli was by far superior to that of SCE 963, T 1551 and cefmetazole, was almost the same as that of SCE 963 and cefmetazole against Staphylococcus aureus infection and that of ticarcillin against P. aeruginosa infection.
Since the advent of cefazolin", various other cephalosporins-" and cephamycins') have been developed in Japan. Of these, cefotiam (SCE 963)3', cefoperazone (T 1551)" and cefmetazole (CS 1170)'' are reported to be antibacterial against some strains of Gram-negative bacteria resistant to currently available cephalosporins.
In a continuous effort to develop better cephalosporins, a great number of derivatives have been synthesized and evaluated in the Fujisawa Research Laboratories. Recently, we have succeeded in developing ceftizoxime (FK 749), a distinctive new cephalosporin antibiotic ( Fig. 1) , which is potently active against both Gram-positive and Gram-negative bacteria including the opportunistic pathogens.
In this study we compared the in vitro and in vivo antibacterial activities of FK 749 with those of three other new Japanese antibiotics and report here the results.
Materials and Methods

I. Antibiotics
The antibiotics used in this study included ceftizoxime (FK 749, Fujisawa, Japan) , cefotiam (SCE 963, Takeda, Japan), cefoperazone (T 1551, Toyama, Japan), cefmetazole (CS 1170, Sankyo, Japan), Full adress: Dr. M. NISHIDA Director of Chemotherapy Research Division; Research Laboratories, Fujisawa Pharmaceutical Co ., Ltd., 1-6, 2-Chome, Kashima, Yodogawa-ku, Osaka 532, Japan THE JOURNAL OF ANTIBIOTICS DEC. 1979 ticarcillin (Beecham, England) and gentamicin (Schering, U.S.A.).
Bacterial strains
Standard strains maintained in our laboratory were used in this study. Clinical isolates of various species of bacteria were supplied by several hospitals in Japan.
Antibiotic susceptibility
Minimum inhibitory concentration (MIC) was determined by the agar dilution method using Heart infusion agar (HI agar, Diico), unless otherwise specified. For the testing of Haemophilus influen.ae and Streptococci, the medium was supplemented with 5°,, defibrinized horse blood. The inoculum was grown in Trypticase soy broth (BBL) overnight at 37'C for all cultures except the above bacteria; each broth was supplemented with 10° Fildes-enrichment (Difco) for H. influenzae and Streptococci. An overnight broth culture and decimal dilutions thereof were streaked or spot-inoculated onto the agar media containing graded concentrations of the test antibiotics. MIC was estimated after incubation at 37 C for 20 hours. For the testing of Bacteroides /i•agilis, the incubation was performed by the GAS-PAK method at 37-C; GAM-broth (Nissui) and GAM-agar (Nissui) were used for the preculture and test culture, respectively.
Minimum bactericidal concentration (MBC)
Each HI-broth containing graded concentrations of the test antibiotics was inoculated with test organisms to obtain a concentration of about 10" colony forming units (C.F.U.)/ml. After incubating at 37,C for 18 hours, the MBC was estimated as the lowest antibiotic concentration to kill 99.9";, of the bacterial cells inoculated.
Stability to /3-lactamases
(1) Preparation of /3-lactamase: The cells were grown at 37 C in HI-broth to which penicillin G was added as an inducer. After overnight incubation, the cells were harvested by centrifugation, washed once and suspended in 0.067 M phosphate buffer (pH 7.0). The cell suspensions were sonicated at 20 Kc for 20 minutes. After cellular debris was removed by centrifugation, the supernatant was subjected to gel filtration on a Sephadex G100 column. The column was equilibrated with 0.067 M phosphate buffer (pH 7.0) and eluted with the same buffer. The enzyme-containing fractions were pooled and stored at -20°C.
(2) Assay of fl-lactamase activity: /3-Lactamase activity was determined with a Hitachi 200-20 spectrophotometer equipped with a thermostatted cell holder. The enzyme was mixed in a 1-cm ,quartz cuvette with 150 ,tag of substrate and 200 ftmoles of 0.067 M phosphate buffer (pH 7.0) to a final volume of 3.0 nil and incubated at 37°C. The rate of hydrolysis of the j3-lactam ring was followed by the change in UV-absorption at 240 nm for penicillin G and at 260 nm for cephalosporins. The relative initial rates of hydrolysis was expressed as a percentage of the rate hydrolysis of cephaloridine for cephalosporinase and that of penicillin G for penicillinase.
6. Therapeutic effect on experimental infections in mice Each organism cultured overnight on Trypticase soy agar (BBL) at 37 C, was suspended in a 5 °,, mucin solution to obtain specified cell counts. Male JCL-ICR strain mice aged 4 weeks (18.5 -21.5 g) were used and each group consisted of 10 mice. Mice were inoculated intraperitoneally with 0.5 nil of the suspension and were given a single subcutaneous dose of the test antibiotics 1 hour after challenge. The mean ED.," value was found by the probit method from the number of mice sursiving 4 days of observation.
Results
Antibacterial Activity
The antibacterial activity of FK 749 against clinical isolates was compared with that of SCF 963, Sodium(6R,7R)-7-[(Z)-2-methoxyiminc-2-(2-aminothiazole-4-yl)acetamidol-8-oxo-5-thia-I-a abicyclo [4, 2, 0] and were somewhat inferior to SCE 963 and cefmetazole (mean: 1.37 and 1.78 pg/ml, respectively).
No strains of S. aureus were resistant to any of the test antibiotics including FK 749. In contrast, the MICs of FK 749 for 40 strains of Staphylococcus epidermidis ranged from 0.2 to >_200 /tg/ml (mean: 1.92 pg/ml). The activity of FK 749 against this group of organism was superior to that of cefmetazole and T-1551 but was inferior to that of SCE 963. As a whole, strains of S. p}'ogenes were susceptible to all the antibiotics, especially to FK 749. The MICs of FK 749 for 40 strains of S. progenes were 0.025 pg/ml or lower, and the drug was the most effective of all the antibiotics tested against this organism.
In general, marked differences between FK 749 and the reference antibiotics were found in antibacterial activity against Gram-negative bacteria:
The mean MICs against 84 strains of E. coli were 0.11 pg/mI for FK 749, 0.42 /tg/ml for SCE 963, 0.90 pg/ml for T 1551 and 2.28 pg/nil for cefmetazole. The activity of FK 749 against these strains was superior to that of the other antibiotics tested. No strains of E. coli were resistant to FK 749. The activity of FK 749 against 84 strains of K. pneumoniae was the most potent, with a mean MIC of 0.048 pg/ml, followed in descending order by SCE 963 (0.73 pg/ml), cefmetazole (1.91 pg/ml) and T 1551 (1.94 pg,/n-il). None of the 84 strains of k. pneumoniae were resistant to FK 749, but 6 strains were resistant to T 1551 (MIC: >I 00 pg/ml).
The M1Cs of FK 749 for 84 strains of P. mirabilis ranged from ----0.025 to 1.56 pg/ml. The activity of FK 749 against these strains was the most potent; the mean MICs were 0.029 pg/ml for FK 749, 1.10 pg/nil for SCE 963, 2.16 pg/mI for T 1551, and 4.68 pg/ml for cefmetazole. FK 749 was also the most effective of all the antibiotics against indole-positive Proteus species; the mean MICs of FK 749
were 0.048 pg/ml for P. iulgaris, 0.46 pg/mI for P. morganii, 0.033 pg/ml for P. rettgeri and 0.045 pg/ml for P. inconstans B. No strains were resistant to FK 749.
The mean MIC of FK 749 for 42 strains of C. Jreundii was 1.42 pg/ml. Of these, only 3 were highly resistant (MIC: 100 pg/ml or higher). In contrast, the MICs for these strains were 5.95 pg/ml for SCE 963, 2.14 pg/nil for T 1551 and 93.6 /ig/ml for cefmetazole. Strains resistant to SCE 963, cefinetazole and T 1551 were found more frequently than those to FK 749. The MICs of FK 749 ranged from 0.05 to 100 pg/ml (mean: 1.02 //g/ml) for 42 strains of E. aerogenes and from 0.1 to >200 pg/ml (2.08 pg/ml) for E. cloacae. The activity of FK 749 against Enterobacter species was the most potent of all the antibiotics tested. Cefinetazole was scarcely active against this bacterial species.
Most of the 42 strains of S. marcescens were resistant to SCE 963, cefmetazole and T 1551, however, these strains were susceptible to FK 749 and the MICs ranged from 0.1 to 25 jig/nil (mean: 1.97 jig/ml). The 40 strains of H. influenzae were highly susceptible to FK 749 and the activity of FK 749 against these strains was the most potent (mean MIC: '0.025 pg/ml) of all the drugs tested. The MICs of FK 749 for Bacteroides fragilis (16 strains) ranged from 0.39 to 50 /ig/ml (mean: 7.43 pg/ml).
The activity of FK 749 against these strains was the most potent, followed in descending order by cefmetazole, T 1551 and SCE 963.
The antibacterial activity of FK 749 against P. aeruginosa was compared with that of ticarcillin (TIPC), T 1551 and gentamicin (GM). The activity of FK 749 against 42 strains of P. aeruginosa was similar to that of ticarcillin but was inferior to that of T 1551 and gentamicin. No. of organisms with a MIC (pg/ml) of: Ampicillin-resistant clinical isolates of E. co/i and K. pneumoniae were classified into those whose resistance was chromosomal and those whose resistance was mediated by an R-plasmid. The antibacterial activity of FK 749 against these strains was compared with that of SCE 963, T 1551 and cefinetazole in two sizes of inocula (10° and 10' C.F.U./rnl) ( Table 2) . The antibacterial activity of FK 749 against both types of resistant strains of K. pneumoniae was also superior to that of the other antibiotics at both sizes of inocula. The mean MICs of FK 749 for these strains of K. pneumoniae were about the same as those of E. coli given above.
Minimum Bactericidal Concentration (MBC)
The MBCs of FK 749 against E. colt, K. pneumoniae and P. mirahilis were compared with those of SCE 963, cefmetazole and T 1551 ( Table 3 ). The bactericidal activity of FK 749 against 8 strains of E. coli was the most potent of all the drugs tested, with a mean MBC of 2.5 pg,/nil, and was 2.7-5 times lower than that of the three other antibiotics. Similar results were obtained with 7 strains of K. pneumoniae. The activity of FK 749 was the most potent of all the test drugs (mean MBC: 0.12 pg/nil) and was respectively about 2.8, 39 and 158 times lower than that of SCE 963, cefmetazole and T 1551. Generally. P. inirabi/is was somewhat resistant to the bactericidal activity of these antibiotics.
The MBC of FK 749 for the 5 strains, however, was 22 /!g/ml and showed a definite bactericidal effect.
The MBCs of the other antibiotics were 100 pg/nil or higher; they had no marked bactericidal activity.
Stability of /7-Lactaniases
The hydrolysis of FK 749 by cephalosporinase (/)'-lactamase la) and penicillinase (/3-lactaniase 111) vvas compared with that of the reference antibiotics. The relative initial rates of hydrolysis were expressed in percentage of hydrolysis of cephaloridine for cephalosporinase and in that of penicillin 6 for penicillinase. Table 4 shows that FK 749 was extremely stable to both types of //-lactamases MBC was determined as the lowest concentration that kills 99.9 of the inoculum (10' C.F.U./ml). sporin, FK 749, which has high antibacterial potency and which meets the actual requirements for treatment of infections due to Gram-negative pathogens including the opportunistic pathogens'). FK 749 is distinguished by its exceptional antibacterial activity against frequently encountered pathogens such as E. co/i, K. pneumoniae, Proteus species, H. influenzae and S. pvogenes and also against Enterobacter and Citrobacter species and S. marcescens. The excellent antibacterial activity of FK 749 against Gram-negative bacterial species is well evidenced by the following main characteristics; high permeability of the outer membrane of the bacterial cell (H. Kojo, Y. SHiGl, M. NISHIDA, unpublished data) and stability to hydrolysis by /3-lactamase located in the periplasm.
In contrast, the activity of FK 749 against P. aeruginosa is similar to that of ticarcillin and is the weakest against this species of Gram-negative bacilli. It is generally considered that the susceptibility of P. aeruginosa to fl-lactam antibiotics is decreased due to limited permeability of antibiotics to the bacterial cells. However, the practical worth of FK 749 against pseudomonal infection remains to be clinically evaluated.
In view of the fact our studies of FK 749 showed the drug to be more potent than other newly developed Japanese antibiotics in various in vitro and in vivo tests against Gram-negative bacilli except P. aeruginosa, we strongly believe that FK 749 has considerable potential for clinical application. Antimicr. Agents & Chernoth. in press. 1979 
